ClinicalTrials.Veeva

Menu

Clinical and Radiographic Evaluation of Propolis As a Hemostatic Agent for Pulpotomy of Mature Permanent Molars with Irreversible Pulpitis Using Two Different Dressing Materials

M

Misr International University

Status and phase

Active, not recruiting
Phase 2

Conditions

Pulpitis
Irreversible Pulpitis
Pulpitis - Irreversible

Treatments

Procedure: Full pulpotomy using sodium hypochlorite and bioceramic putty
Procedure: Full pulpotomy using sodium hypochlorite and MTA
Procedure: Full pulpotomy using Propolis and MTA
Procedure: Full pulpotomy using propolis and bioceramic putty

Study type

Interventional

Funder types

Other

Identifiers

NCT06679075
MIU-IRB-2324-047

Details and patient eligibility

About

The goal of this clinical trial is to assess the effectiveness of propolis as a hemostatic agent in pulpotomy for adult permanent molars, compared to sodium hypochlorite (NaOCl). It also examines how bioceramic putty performs against mineral trioxide aggregate (MTA) in vital pulp therapy for cases of irreversible pulpitis.

Participants will be divided into four groups (15 patients each):

  • Propolis + bioceramic putty
  • Propolis + MTA
  • Sodium hypochlorite + bioceramic putty
  • Sodium hypochlorite + MTA The Investigator will record the bleeding time and postoperative pain will be recorded. The researcher will assess the clinical and radiographic outcomes for success at 1, 3, and 6 months.

Enrollment

60 estimated patients

Sex

All

Ages

20 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants of both genders falling within the age range of 20 to 45 years.
  • Presence of vital mature permanent molars diagnosed as mild or severe irreversible pulpitis per Wolter's classification.
  • Confirmation of vital bleeding pulp tissue in all canals following complete pulpotomy.

Exclusion criteria

  • Non-vital teeth.
  • Teeth with Immature roots.
  • Uncontrolled pulpal bleeding persisting beyond 10 minutes post-application of sodium hypochlorite as a hemostatic agent.
  • Insufficient bleeding post-pulp exposure, indicative of pulp degeneration.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 4 patient groups

Propolis + Bioceramic putty
Experimental group
Description:
Adult permanent molars diagnosed with irreversible pulpitis to be treated with full pulpotomy using propolis as a hemostatic agent and bioceramic putty as a dressing material.
Treatment:
Procedure: Full pulpotomy using propolis and bioceramic putty
Propolis + MTA
Experimental group
Description:
Adult permanent molars diagnosed with irreversible pulpitis to be treated with full pulpotomy using propolis as a hemostatic agent and MTA as a dressing material.
Treatment:
Procedure: Full pulpotomy using Propolis and MTA
Sodium hypochlorite + bioceramic putty
Experimental group
Description:
Adult permanent molars diagnosed with irreversible pulpitis to be treated with full pulpotomy using sodium hypochlorite (NaOCl) as a hemostatic agent and bioceramic putty as a dressing material.
Treatment:
Procedure: Full pulpotomy using sodium hypochlorite and bioceramic putty
Sodium hypochlorite + MTA
Active Comparator group
Description:
Adult permanent molars diagnosed with irreversible pulpitis to be treated with full pulpotomy using sodium hypochlorite (NaOCl) as a hemostatic agent and MTA as a dressing material
Treatment:
Procedure: Full pulpotomy using sodium hypochlorite and MTA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems